Detalhe da pesquisa
1.
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors.
Cell
; 185(10): 1745-1763.e22, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483375
2.
Engineered CD47 protects T cells for enhanced antitumour immunity.
Nature
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750365
3.
Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.
Proc Natl Acad Sci U S A
; 116(3): 997-1006, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602457
4.
A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced Brain, Heart, and Bone Injuries in Pediatric Cancer Survivors: A Pilot Study.
Radiology
; 285(3): 971-979, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28777701
5.
Prospective analysis of long-term renal function in survivors of childhood Wilms tumor.
Pediatr Nephrol
; 32(10): 1915-1925, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28451896
6.
Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.
Childs Nerv Syst
; 33(8): 1275-1283, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28488085
7.
Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma.
Pediatr Hematol Oncol
; 33(4): 264-75, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27285993
8.
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639156
9.
MRI Correlates of Ototoxicity in the Auditory Pathway in Children Treated for Medulloblastoma.
Otol Neurotol
; 43(1): e97-e104, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739428
10.
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Nat Med
; 28(2): 333-344, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027753
11.
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.
Cancer Cell
; 40(1): 53-69.e9, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971569
12.
Tuning the Antigen Density Requirement for CAR T-cell Activity.
Cancer Discov
; 10(5): 702-723, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193224
13.
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.
Nat Med
; 26(5): 712-719, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32341579
14.
Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on.
Mol Oncol
; 13(10): 2049-2061, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376208
15.
Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma.
Cell Death Dis
; 10(2): 36, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674867
16.
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.
Clin Cancer Res
; 25(8): 2560-2574, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655315
17.
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Sci Signal
; 11(547)2018 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206138
18.
Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.
Nat Commun
; 9(1): 4651, 2018 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30389946
19.
Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.
Nat Commun
; 9(1): 4121, 2018 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297829
20.
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
Oncotarget
; 7(50): 83378-83391, 2016 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825128